RGS2 and cancer: Although such a role of RGS2 may be potentially beneficial as a target to enhance cancer immunotherapy, it is conceivable that cardiac-specific homing or recruitment of T cells with increased RGS2 expression or function can predispose to myocardial injury and DCM as occurs in anthracycline-induced cardiomyopathy (82).